统计方法用于中央统计监测的应用和在德国多发性硬化病登记处的实施
Firas Fneish1,2, David Ellenberger3, Niklas Frahm3
1Department of Biostatistics, Institute of Cell Biology and Biophysics, Leibniz University Hannover, Herrenhäuser Straße 2, 30419, Hannover, Germany. fneish@cell.uni-hannover.de.
Therapeutic innovation & regulatory science
|July 14, 2023
概括
中央统计监测 (CSM) 为传统的临床试验监督提供了一个具有成本效益的替代方案. 本研究引入了CSM的新统计方法,提高了临床研究中的数据完整性和监管合规性.
科学领域:
- 临床试验 临床试验
- 生物统计学 生物统计学
- 监管科学 监管科学
背景情况:
- 传统的临床试验监测依赖于昂贵的现场访问和源数据验证.
- 中央统计监测 (CSM) 越来越多地被采用来有效地检测数据错误.
- 现有的CSM方法主要集中在内向/外向检测上.
研究的目的:
- 为CSM引入和评估新的统计方法.
- 将个别临床试验中心与各种数据类型的"大平均值"进行比较.
- 评估这些方法在控制错误和功率方面的性能.
主要方法:
- 利用中心与二项式,顺序式和连续数据的大平均值的比较.
- 实现了单个中心与大平均值的多重比较.
- 适用于同等性评估的可信度区间.
- 进行蒙特卡洛模拟,用于I型错误控制和功率分析.
- 使用来自德国多发性硬化病注册表 (GMSR) 的现实世界数据验证的方法.
主要成果:
- 提出的统计方法有效控制了I型错误.
- 这些方法在检测平衡和不平衡研究设计中的偏差方面表现出强大作用.
- 现实世界的数据分析证实了CSM技术的适用性和有效性.
结论:
- 新的统计方法加强了临床试验的中央统计监测.
- 这些方法改善了数据质量评估和监管合规性.
- 已验证的CSM技术适用于各种数据类型和研究设计,包括注册表数据.
相关概念视频
Statistical Methods for Analyzing Epidemiological Data
420
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
420
Statistical Software for Data Analysis and Clinical Trials
642
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
642
Kaplan-Meier Approach
188
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
188
Comparing the Survival Analysis of Two or More Groups
226
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
226


